Venlafaxine Use Linked to Bone Turnover Markers in Older Adults

Depression treatment with venlafaxine is associated with increased levels of the bone resorption marker C-terminal cross-linking telopeptide of type 1 collagen, as well as decreased levels of the bone formation marker procollagen type 1 N-propeptide, according to a study published online May 26 in the Journal of the American Geriatrics Society.